Travere Therapeutics, Inc. Common Stock (TVTX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TVTX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 8,020,663 | $456M | INCREASED |
| State Street | 4,256,224 | $242M | DECREASED |
| Stephens Investment Management Group | 1,875,304 | $107M | INCREASED |
| Emerald Advisers | 1,600,886 | $91M | INCREASED |
| Emerald Mutual Fund Advisers Trust | 1,032,024 | $59M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jula Inrig (CHIEF MEDICAL OFFICER) | GIFT | 468 | 2026-06-22 | |
| Roy D. Baynes (Director) | EXERCISE | 4,500 | $96K | 2026-06-12 |
| Roy D. Baynes (Director) | SELL | 4,500 | $225K | 2026-06-12 |
| Timothy Coughlin (Director) | EXERCISE | 10,000 | $265K | 2026-06-12 |
| Timothy Coughlin (Director) | SELL | 10,000 | $501K | 2026-06-12 |
Full institutional holdings, insider history, and congressional trades for Travere Therapeutics, Inc. Common Stock on SentiSense.